Advertisement

Diabetes and Doping

  • Richard I. G. Holt
Chapter

Abstract

When humans are placed in a competitive setting, particularly in the sporting arena, they will attempt to gain an advantage over their opponent in order to win. When all legitimate methods have been exhausted and the athlete has reached their peak performance, there is a temptation for some to seek out pharmacological methods to improve performance yet further. Doping not only damages the integrity of sport but may cause significant harm to athletes who use performance-enhancing drugs, including athletes with type 1 diabetes.

Keywords

Growth Hormone Growth Hormone Deficiency Olympic Game Anabolic Androgenic Steroid National Football League 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

I would like to thank Michael Stow of UK Anti-Doping for his helpful comments on the chapter.

References

  1. 1.
    Holt RI, Erotokritou-Mulligan I, Sonksen PH. The history of doping and growth hormone abuse in sport. Growth Horm IGF Res. 2009;19(4):320–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Yesalis CE, Bahrke MS. History of doping in sport. In: Bahrke MS, Yessalis CE, editors. Performance-enhancing substances in sport and exercise. 1st ed. Champaign: Human kinetics; 2002. p. 1–20.Google Scholar
  3. 3.
    Wilson JD. Androgen abuse by athletes. Endocr Rev. 1988;9(2):181–99.PubMedCrossRefGoogle Scholar
  4. 4.
    Bagatell CJ, Bremner WJ. Androgens in men–uses and abuses. N Engl J Med. 1996;334(11):707–14.PubMedCrossRefGoogle Scholar
  5. 5.
    Geraci MJ, Cole M, Davis P. New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder. Hum Exp Toxicol. 2011;30(12):2007–12.Google Scholar
  6. 6.
    Sawka MN, Muza SR, Young AJ. Erythrocyte volume expansion and human performance. In: Fourcroy JL, editor. Pharmacology, doping and sports. a scientific guide for athletes, physicians, scientists and administrators. Abingdon: Routledge; 2009. p. 125–34.Google Scholar
  7. 7.
    Fernandez-Reyes MJ, Selgas R, Bajo MA, Jimenez C, Del PG, Sanchez MC, et al. Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: is there a synergistic effect with insulin? Perit Dial Int. 1995;15(6):231–5.PubMedGoogle Scholar
  8. 8.
    Liu H, Bravata DM, Olkin I, Friedlander A, Liu V, Roberts B, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148(10):747–58.PubMedGoogle Scholar
  9. 9.
    Guha N, Sonksen PH, Holt RI. IGF-I abuse in sport: current knowledge and future prospects for detection. Growth Horm IGF Res. 2009;19(4):408–11.PubMedCrossRefGoogle Scholar
  10. 10.
    Holt RI, Sonksen PH. Growth hormone, IGF-I and insulin and their abuse in sport. Br J Pharmacol. 2008;154(3):542–56.PubMedCrossRefGoogle Scholar
  11. 11.
    Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet. 1997;350(9086): 1199–204.PubMedCrossRefGoogle Scholar

Further Reading Books

  1. Fainaru-Wada M, Gotham LW. Game of shadows: Barry Bonds, BALCO, and the steroids scandal that rocked professional sports. 1st ed. 2006; pp. 352. ISBN-10: 9781592401994.Google Scholar
  2. Fourcroy JL. Pharmacology, doping and sports: a scientific guide for athletes, coaches, physicians, scientists and administrators. 1st ed. Routledge; 2008, pp. 240. ISBN-10: 0415578221.Google Scholar

Themed Journal Issues

  1. McGrath I, Cowan D, Guest Editors. Drugs in sport. Br J Pharmacol. 2008; 154(3).Google Scholar
  2. Sonksen PH, Holt RIG, Guest Editors. The abuse of growth hormone in sport and its detection: a medical, legal and social framework. Growth Hormone IGF Res. 2009;(4).Google Scholar

Useful Websites

  1. UK Anti-Doping: http://www.ukad.org.uk/
  2. US Anti-Doping Agency: http://www.usantidoping.org/
  3. World Anti-Doping Agency: http://www.wada-ama.org/

Copyright information

© Springer-Verlag London 2012

Authors and Affiliations

  1. 1.Human Development and Health Academic UnitUniversity of Southampton, Faculty of MedicineSouthamptonUK

Personalised recommendations